It is confirmed that PRep decreases the HIV infection risk if taken regularly Though the drug is endorsed by the World Health Organisation and is available to at-risk gay men in a number of countries, NHS England has repeatedly deferred a decision on the drugs – despite a pilot scheme showed the drugs were incredibly effective at reducing HIV transmission among men who have sex with men (MSM). This week, NHS England ruled out a large scale roll-out for PrEP instead funding a further two-year trial at “early implementer” sites.
Stephen Fry could not stay away from the situation, he claimed: “I have been a supporter of HIV charities for 35 years and seen remarkable medical and social breakthroughs in treating infection and stigma. But I never imagined I would be alive to see the day when a pill was created that could actually prevent HIV. It is remarkable and thrilling to witness so tremendous an achievement, but deeply frustrating in equal measure to discover that our national health service has pointedly refused to provide it to people at significant risk of infection from HIV. Surely this must be challenged: if not in the name of humanity then in the name of economy and plain common sense.”